Clinical trial
Evaluation of Sentinel Lymph Node Detection After Neoadjuvant Chemotherapy for Large Operable Breast Cancer
NCT01221688 is registered in ClinicalTrials.gov with Institut Cancerologie de l'Ouest as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Sentinel Lymph Node Detection After Neoadjuvant Chemotherapy for Large Operable Breast Cancer
- Lead sponsor
- Institut Cancerologie de l'Ouest
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 12, 2010
- Completion date
- December 10, 2019
- Enrollment
- 958 (actual)
- Sites
- 18
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer